title: [The prevention of postinfarction left ventricular dilatation by captopril].
abstract: Thirty patients admitted to the ICCU with a first myocardial infarction (MI) of any localization, with left ventricular dysfunction revealed by echo-Doppler ejection fraction (EF) < 40%, where randomly divided in three groups of ten: GROUP 1 who was treated with captopril 25 mg orally between the 5th and 7th day post MI, and sustained until the end of the study. GROUP 2 received nifedipine, 10 mg capsules t.i.d. also started between days 5 and 7 post MI. GROUP 3 as a control group was treated conventionally, according to the ICCU routine. The treatment was maintained during 12 months. All patients had a second echo-Doppler at the 5th day post MI to confirm the EF criteria. Also left ventricular end-systolic and end-diastolic diameters were measured. At the 5th day post MI and before the drug administration, a low level treadmill stress test was performed in all patients. Subsequently a maximal stress test (Bruce protocol) was done at the first month and at 6 and 12 months of the study. The results showed a significant increase EF in patients of GROUP 1 from an average basal value of 38 +/- 2 to 54 +/- 5 at six months (p < 0.01) and to 60 +/- 3 at 12 months (p < 0.005). The increments observed in patients of GROUP 2 and 3 were more modest; only the 12 month value in GROUP 3, from a basal figure of 41 +/- 3 to 50 +/- 4, had a p < 0.05.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: División de Cardiología, Hospital de Cardiología Luis Méndez, Centro Médico Nacional, México, D.F.
authors.forename: J
authors.initials: J
authors.lastname: Villalpando Gutiérrez
authors.forename: J
authors.initials: J
authors.lastname: Navarro-Robles
authors.forename: R
authors.initials: R
authors.lastname: Tello-Osorio
authors.forename: J
authors.initials: J
authors.lastname: Borges-Moreno
authors.forename: H
authors.initials: H
authors.lastname: Lozano-de los Santos
mesh_terms: D000328:Adult; D000368:Aged; D002216:Captopril / Q000008:administration & dosage*; D017079:Exercise Tolerance / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000503:physiopathology; D009543:Nifedipine / Q000008:administration & dosage; D013997:Time Factors
chemical_list: D002216:Captopril; D009543:Nifedipine
vernacular_title: Prevención de la dilatación del ventrículo izquierdo postinfarto del miocardio por captopril.